The field of cell and gene therapies (CGTs) has witnessed remarkable progress in recent years, offering unprecedented potential for transforming the landscape of medicine and the lives of patients. As the promise of CGTs increasingly transitions to reality, it is imperative to ensure that regulatory and legislative policies evolve in parallel to foster safe, efficient product development and broader patient access. The policy summit, 1 American Society of Gene and Cell TherapyASGCT Policy Summit. 2023https://asgct.org/advocacy/policy-summit Google Scholar hosted by the American Society of Gene and Cell Therapy (ASGCT) in Washington, DC, is a critical forum for facilitating these discussions.